Comprehensive prioritisation scheme for active pharmaceutical ingredients in Denmark

Key Points

• A comprehensive prioritization scheme identifies high-risk active pharmaceutical ingredients in Denmark, addressing environmental risks.
• This analysis focuses on 2574 approved APIs in Denmark, pointing to the need for targeted monitoring efforts.
• The study employs a prioritization framework to assess potential adverse effects on the environment from released APIs.
• Findings may enable more efficient environmental monitoring initiatives for pharmaceuticals in Denmark.